Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Gains 16%; BSE HEALTHCARE Index Up 1.1%
Thu, 4 Jul 13:5

ASTRAZENECA PHARMA Gains 16%; BSE HEALTHCARE Index Up 1.1%Image source: phive2015/www.istockphoto.com

ASTRAZENECA PHARMA share price has zoomed 16% and is presently trading at Rs 7,392.2.

Meanwhile, the BSE HEALTHCARE index is at 37,847.9 (up 1.1%).

Among the top gainers in the BSE HEALTHCARE index today are Lupin (up 6.7%) and LAURUS LABS (up 4.9%).

ERIS LIFESCIENCES (down 1.2%) and SUVEN PHARMACEUTICALS (down 1.1%) are among the top losers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 3,791.4 to Rs 7,392.2, registering a gain of Rs 3,600.9 (up 95.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,627.6 to 37,847.9, registering a gain of 47.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 97.0%), Lupin (up 95.0%) and ASTRAZENECA PHARMA (up 95.0%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,231.0 (up 0.3%).

The top gainers among the BSE Sensex today are HCl Tech. (up 3.0%) and ICICI Bank (up 2.0%). The most traded stocks in the BSE Sensex are HDFC Bank and Tata Steel.

In the meantime, NSE Nifty is at 24,349.0 (up 0.3%). HCl Tech. and ICICI Bank are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,205.1 to 80,231.0, registering a gain of 15,026.0 points (up 23.0%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit grew 128.6% YoY to Rs 395 million for the quarter ended March 2024, compared to a profit of Rs 173 million a year ago. Net sales rose 34.6% to Rs 3,832 million during the period as against Rs 2,847 million in January-March 2023.

For the year ended March 2023, ASTRAZENECA PHARMA reported 61.2% increase in net profit to Rs 993 million compared to net profit of Rs 616 million during FY22. Revenue of the company grew 24.5% to Rs 10,030 million during FY23.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 114.4.


Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Gains 16%; BSE HEALTHCARE Index Up 1.1%". Click here!